Source:http://linkedlifedata.com/resource/pubmed/id/18245174
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-6-3
|
pubmed:abstractText |
Enhanced transforming growth factor (TGF) -beta signaling contributes to idiopathic pulmonary fibrosis (IPF), a progressive and fatal disease characterized by alveolar epithelial type II (ATII) cell hyperplasia, (myo)fibroblast accumulation, and excessive extracellular matrix deposition. TGF-beta is a potent inducer of lung fibrosis, and it regulates the ATII cell phenotype; however, direct TGF-beta target genes controlling the ATII cell phenotype remain elusive. Here, we identified the transgelin (tagln) gene as a novel immediate target of TGF-beta/Smad3-dependent gene expression in ATII cells using a Smad3 chromatin immunoprecipitation (ChIP) screen. Direct ChIP confirmed the rapid and specific binding of Smad3 to the tagln promoter. Luciferase assays demonstrated transactivation of the tagln promoter by activin-like kinase (Alk) 5-mediated TGF-beta signaling. TGF-beta treatment resulted in rapid up-regulation of tagln, but not tagln2, mRNA and protein expression, assessed by reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, and immunofluorescence. In vivo, tagln expression was significantly increased in ATII cells of mice during bleomycin-induced lung fibrosis, as well as in lung specimen obtained from IPF patients, as assessed by RT-PCR and immunohistochemistry. Knockdown of tagln using siRNA inhibited TGF-beta-induced migration of lung epithelial A549 cells, as well as primary ATII cells. We thus identified tagln as a novel target of TGF-beta/Smad3-dependent gene expression in ATII cells. Increased ATII cell expression of tagln in experimental and idiopathic pulmonary fibrosis may contribute to TGF-beta-dependent ATII cell injury, repair, and migration in lung fibrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Microfilament Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Muscle Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/Smad3 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/transgelin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1530-6860
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1778-89
|
pubmed:dateRevised |
2011-11-10
|
pubmed:meshHeading |
pubmed-meshheading:18245174-Cell Line,
pubmed-meshheading:18245174-Cell Movement,
pubmed-meshheading:18245174-Epithelial Cells,
pubmed-meshheading:18245174-Humans,
pubmed-meshheading:18245174-Microfilament Proteins,
pubmed-meshheading:18245174-Muscle Proteins,
pubmed-meshheading:18245174-Promoter Regions, Genetic,
pubmed-meshheading:18245174-Pulmonary Fibrosis,
pubmed-meshheading:18245174-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:18245174-Smad3 Protein,
pubmed-meshheading:18245174-Transforming Growth Factor beta
|
pubmed:year |
2008
|
pubmed:articleTitle |
Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis.
|
pubmed:affiliation |
University of Giessen Lung Center, Department of Medicine II, Justus Liebig University Giessen, D-35392 Giessen, Germany.
|
pubmed:publicationType |
Journal Article
|